Arkuda Therapeutics
PrivateLast Round
Series B
Feb 10, 2022
Total Funding Raised
$108M
Company Overview
Arkuda Therapeutics is a biotechnology company that develops neurodegenerative medicines by leveraging insights into progranulin and lysosomal biology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arkuda Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Arkuda Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 10, 2022 | ||||
| Series A | Nov 7, 2019 |
Arkuda Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series B |
| Cormorant Asset Management | Series B |
| BioInnovation Capital | Series A, Series B |
| Pivotal bioVenture Partners | Series B |
| Tekla Capital Management | Series A, Series B |
| Nan Fung Group | Series B |
| Citadel | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 10, 2022
$64M round led by Cormorant Asset Management, Pivotal bioVenture Partners China, and Nan Fung Group.
- Nov 7, 2019
$44M round led by Pfizer Ventures and Atlas Venture.
Arkuda Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arkuda Therapeutics's valuation, stock price, and market status.